https://glp-1-based-therapeutics.com/ 2026-03-26T13:28:53+00:00 https://glp-1-based-therapeutics.com/sponsor/eforto/ 2026-04-01T09:39:18+00:00 https://glp-1-based-therapeutics.com/sponsor/edgeone-medical/ 2026-03-25T14:07:58+00:00 https://glp-1-based-therapeutics.com/speaker/robert-beardsley/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/timothy-kieffer/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/barry-wark-2/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/sponsor/bd-becton-dickinson/ 2026-03-23T10:23:19+00:00 https://glp-1-based-therapeutics.com/speaker/barry-wark/ 2026-03-24T13:57:43+00:00 https://glp-1-based-therapeutics.com/sponsor/onesource-specialty-pharma-limited/ 2026-03-20T11:48:22+00:00 https://glp-1-based-therapeutics.com/sponsor/revise/ 2026-03-23T14:53:01+00:00 https://glp-1-based-therapeutics.com/speaker/antaros-medical/ 2026-03-18T10:06:47+00:00 https://glp-1-based-therapeutics.com/speaker/perspectum/ 2026-03-18T10:06:13+00:00 https://glp-1-based-therapeutics.com/about/industry-news/ 2026-03-03T10:52:33+00:00 https://glp-1-based-therapeutics.com/sponsor/ovation/ 2026-02-24T14:24:25+00:00 https://glp-1-based-therapeutics.com/sponsor/40800-2/ 2026-03-09T16:38:47+00:00 https://glp-1-based-therapeutics.com/speaker/cecilie-jepsen/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/alan-baldridge-2/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/alan-baldridge/ 2026-02-27T13:54:38+00:00 https://glp-1-based-therapeutics.com/exhibitor/amra/ 2026-02-05T14:25:57+00:00 https://glp-1-based-therapeutics.com/speaker/jennifer-linge/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/niharika-samala/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/adriana-ramos/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/ashwani-singal/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/punit-dhillon/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/allison-goldfine/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/andrew-young/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/maria-trujillo/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/lawrence-j-olson/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/steven-dickman/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/fady-botros/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/alok-pachori/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/dr-raj-reddy/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/lin-quek/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/steffen-sebastian-bolz/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/winston-dunn/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/belle-van-rosmalen/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/rosemarie-sellati/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/kristin-fiorino/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/speaker/melissa-jones/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/exhibitor/takeda/ 2026-02-05T14:25:57+00:00 https://glp-1-based-therapeutics.com/exhibitor/roche/ 2026-02-05T14:25:53+00:00 https://glp-1-based-therapeutics.com/exhibitor/novo-nordisk/ 2026-02-05T14:25:03+00:00 https://glp-1-based-therapeutics.com/exhibitor/madrigal-pharmaceuticals/ 2026-02-05T14:25:55+00:00 https://glp-1-based-therapeutics.com/exhibitor/altimmune/ 2026-02-05T14:25:50+00:00 https://glp-1-based-therapeutics.com/exhibitor/cirius-therapeutics/ 2026-02-05T14:25:57+00:00 https://glp-1-based-therapeutics.com/exhibitor/fnih/ 2026-02-05T14:25:57+00:00 https://glp-1-based-therapeutics.com/exhibitor/fractyl-laboratories/ 2026-02-05T14:25:55+00:00 https://glp-1-based-therapeutics.com/exhibitor/skye-biosciences/ 2026-02-05T14:25:53+00:00 https://glp-1-based-therapeutics.com/exhibitor/regeneron/ 2026-02-05T14:25:39+00:00 https://glp-1-based-therapeutics.com/exhibitor/eli-lilly/ 2026-02-05T14:25:08+00:00 https://glp-1-based-therapeutics.com/exhibitor/canary-global/ 2026-02-05T14:25:57+00:00 https://glp-1-based-therapeutics.com/exhibitor/aardvark-therapeutics/ 2026-02-05T14:25:11+00:00 https://glp-1-based-therapeutics.com/exhibitor/merck/ 2026-02-05T14:25:55+00:00 https://glp-1-based-therapeutics.com/exhibitor/sanofi/ 2026-02-05T14:25:50+00:00 https://glp-1-based-therapeutics.com/exhibitor/astrazeneca/ 2026-02-05T14:25:11+00:00 https://glp-1-based-therapeutics.com/sponsor/icon/ 2025-11-28T11:24:57+00:00 https://glp-1-based-therapeutics.com/sponsor/perspectum/ 2025-11-25T12:00:59+00:00 https://glp-1-based-therapeutics.com/sponsor/clinical-ink/ 2025-11-25T12:01:38+00:00 https://glp-1-based-therapeutics.com/sponsor/antaros-medical/ 2026-02-03T15:17:38+00:00 https://glp-1-based-therapeutics.com/sponsor/amra-medical/ 2026-02-03T15:19:00+00:00 https://glp-1-based-therapeutics.com/about/events-in-the-series/ 2026-02-03T15:14:32+00:00 https://glp-1-based-therapeutics.com/pre-conference-day/ 2026-02-03T15:12:14+00:00 https://glp-1-based-therapeutics.com/media-partners/ 2026-01-02T10:31:56+00:00 https://glp-1-based-therapeutics.com/why-partner/ 2026-03-18T16:48:12+00:00 https://glp-1-based-therapeutics.com/take-part/poster-session/ 2026-03-25T11:18:18+00:00 https://glp-1-based-therapeutics.com/about-event/ 2026-03-18T14:31:38+00:00 https://glp-1-based-therapeutics.com/thank-you-for-downloading/ 2025-11-24T15:27:34+00:00 https://glp-1-based-therapeutics.com/thank-you-for-registering/ 2026-03-25T13:53:20+00:00 https://glp-1-based-therapeutics.com/contact-us/ 2026-03-18T14:22:10+00:00 https://glp-1-based-therapeutics.com/venue-accommodation/ 2026-03-26T11:55:34+00:00 https://glp-1-based-therapeutics.com/register/ 2026-03-26T13:27:53+00:00 https://glp-1-based-therapeutics.com/day-two/ 2026-02-03T15:11:00+00:00 https://glp-1-based-therapeutics.com/day-one/ 2026-02-03T15:06:50+00:00 https://glp-1-based-therapeutics.com/full-event-guide/ 2026-03-17T15:51:06+00:00 https://glp-1-based-therapeutics.com/about/hanson-wade/ 2026-02-03T15:14:51+00:00 https://glp-1-based-therapeutics.com/speakers/ 2026-02-27T13:58:15+00:00 https://glp-1-based-therapeutics.com/partnership-prospectus/ 2026-03-23T15:19:04+00:00 https://glp-1-based-therapeutics.com/partners/ 2026-02-24T14:24:06+00:00 https://glp-1-based-therapeutics.com/take-part/ 2025-11-19T10:32:43+00:00 https://glp-1-based-therapeutics.com/about/ 2026-02-11T10:56:15+00:00 https://glp-1-based-therapeutics.com/seminar/genetic-biomarkers-of-glp-1-response-insights-into-efficacy-safety-and-patient-stratification-from-real-world-clinico-genomic-data/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/session-reserved-for-novo-nordisk/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/session-reserved-for-metsera/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/session-reserved-for-amra-medical-2/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/chairs-opening-remarks-2/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/end-of-scientific-program-day-1/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/morning-refreshments/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/extending-the-therapeutic-horizon-to-treat-neurological-disorders-addiction-womens-health-to-understand-the-emerging-opportunities-of-glp-1s/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/translating-glp-1-agonism-to-uncover-novel-mechanisms-for-neuroprotection-in-alzheimers-and-parkinsons-disease/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/session-reserved-for-perspectum/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/unlocking-the-potential-of-glp-1s-to-treat-addiction-substance-use-disorders-to-reduce-cravings-impulsivity-to-provide-a-novel-treatment-option/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/morning-break-networking/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/optimizing-glp-1s-for-womens-health-conditions-including-pcos-to-address-hormonal-imbalances-improve-metabolic-function-leading-to-better-clinical-outcomes/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/session-reserved-for-antaros-medical/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/fire-side-discussion-repurposing-glp-1s-to-treat-alzheimers-parkinsons-to-improve-cognitive-function-reduce-neuroinflammation-to-create-a-new-therapeutic-avenue/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/lunch-2/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/seminar/redefining-the-patient-journey-by-improving-side-effects-routes-of-administration-to-enhance-patient-comfort-provide-a-better-quality-of-life-long-term/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/seminar/maximizing-efficacy-minimizing-risk-by-leveraging-peripheral-cb1-antagonism-in-combination-with-glp-1-agonists-to-advance-the-obesity-treatment-paradigm/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/seminar/redefining-the-patient-experience-with-a-first-in-class-oral-gut-restricted-agonist-to-improve-tolerability/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/seminar/afternoon-break-networking/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/seminar/redefining-the-patient-journey-by-leveraging-oral-mpc-modulation-to-enhance-glp-1-tolerability-and-preserve-lean-mass/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/seminar/panel-discussion-collating-the-lessons-learned-from-fda-approved-drugs-to-inform-the-future-of-glp-1-based-therapies-ensure-a-next-generation-of-more-patient-centered-approaches/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/seminar/chairs-closing-remarks-2/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/seminar/end-of-scientific-program-day-2/ 2026-03-24T14:00:07+00:00 https://glp-1-based-therapeutics.com/seminar/session-reserved-for-icon/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/end-of-pre-conference-workshop-day/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/morning-refreshments-check-in/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/lunch-break-networking/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/mapping-the-future-of-glp-1-opportunities-onto-bankable-biotech-business-plans-to-predict-the-billion-dollar-pivot/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/morning-refreshments-check-in-2/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/chairs-opening-remarks/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/unlocking-the-potential-of-combination-therapies-for-broader-clinical-impact-across-indications-for-a-personalized-approach-to-treatment/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/targeting-liver-metabolic-inflammatory-pathways-for-treatment-of-mash/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/speed-networking-session-morning-break/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/showcasing-biotech-innovation-to-disrupt-the-current-glp-1-monopoly-increase-treatment-diversity-in-the-next-generation-of-approved-drugs/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/advancing-targeted-genetic-therapies-with-a-dual-sirna-approach-to-disrupt-the-current-gll-1-monopoly-for-a-more-patient-focused-treatment-diversity/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/accelerating-the-next-wave-of-glp-1-therapies-by-integrating-midd-adaptive-experimental-design-for-de-risking-combinations/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/lunch/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/achieving-better-potency-tolerability-through-pancreas-focused-glp-1r-agonism-with-rejuva-pancreatic-gene-therapy/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/reawakening-the-bodys-natural-hormone-response-through-precision-gut-signaling-to-treat-obesity/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/modernizing-clinical-trials-with-adaptive-design-to-increase-data-quality-accelerate-understanding-of-the-long-term-impact-of-glp-1-drugs/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/roundtable-discussion-re-thinking-chronic-disease-moving-from-symptom-to-cure-for-a-deeper-look-into-the-future-of-glp-1-drugs/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/adopting-innovative-trial-design-endpoints-in-high-risk-masld/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/afternoon-networking-break-poster-session/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/improving-patient-recruitment-retention-with-a-patient-centric-approach-to-accelerate-glp-1-trial-timelines-provides-more-representative-data/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/enhancing-trial-design-using-pre-clinical-clinical-insights-to-optimize-clinical-endpoints-for-mash-drug-development/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/powering-adaptive-glp-1-trial-designs-using-qualifying-biomarkers-for-accelerated-dose-selection-and-multi-indication-insight/ 2026-03-24T14:00:06+00:00 https://glp-1-based-therapeutics.com/seminar/chairs-closing-remarks/ 2026-03-24T14:00:06+00:00